The "psychomicrobiotic": Targeting microbiota in major psychiatric disorders: A systematic review

G. Fond, W. Boukouaci, G. Chevalier, A. Regnault, G. Eberl, N. Hamdani, F. Dickerson, A. Macgregor, L. Boyer, A. Dargel, J. Oliveira, R. Tamouza, M. Leboyer

Research output: Contribution to journalArticle

Abstract

The gut microbiota is increasingly considered as a symbiotic partner in the maintenance of good health. Metagenomic approaches could help to discover how the complex gut microbial ecosystem participates in the control of the host's brain development and function, and could be relevant for future therapeutic developments, such as probiotics, prebiotics and nutritional approaches for psychiatric disorders. Previous reviews focused on the effects of microbiota on the central nervous system in in vitro and animal studies. The aim of the present review is to synthetize the current data on the association between microbiota dysbiosis and onset and/or maintenance of major psychiatric disorders, and to explore potential therapeutic opportunities targeting microbiota dysbiosis in psychiatric patients.

Original languageEnglish (US)
Pages (from-to)35-42
Number of pages8
JournalPathologie Biologie
Volume63
Issue number1
DOIs
StatePublished - Feb 1 2015
Externally publishedYes

Keywords

  • Anxiety
  • Autism
  • Microbiota dysbiosis
  • Probiotic
  • Schizophrenia

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'The "psychomicrobiotic": Targeting microbiota in major psychiatric disorders: A systematic review'. Together they form a unique fingerprint.

  • Cite this

    Fond, G., Boukouaci, W., Chevalier, G., Regnault, A., Eberl, G., Hamdani, N., Dickerson, F., Macgregor, A., Boyer, L., Dargel, A., Oliveira, J., Tamouza, R., & Leboyer, M. (2015). The "psychomicrobiotic": Targeting microbiota in major psychiatric disorders: A systematic review. Pathologie Biologie, 63(1), 35-42. https://doi.org/10.1016/j.patbio.2014.10.003